Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MP7 (PDK1 inhibitor) is a inhibitor of phosphoinositide-dependent kinase-1 (PDK1).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 45.00 | |
5 mg | In stock | $ 110.00 | |
10 mg | In stock | Inquiry | |
50 mg | In stock | Inquiry | |
1 mL * 10 mM (in DMSO) | In stock | $ 125.00 |
Description | MP7 (PDK1 inhibitor) is a inhibitor of phosphoinositide-dependent kinase-1 (PDK1). |
In vitro | MP7 are able to decrease the number of viable cells. When combined together, GSC viability is further reduced with respect to single-treated cells. As observed in U87MG cells, when used at the highest concentrations (i.e., 1.5 μM Alisertib and 2.5 μM MP7), a significant enhancement in the number of dead cells is evidenced. Following 72 h treatment. |
Synonyms | PDK1 inhibitor |
Molecular Weight | 516.5 |
Formula | C28H22F2N4O4 |
CAS No. | 1001409-50-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: ≥ 100 mg/mL (193.61 mM)
H2O: < 0.1 mg/mL (insoluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MP7 1001409-50-2 PI3K/Akt/mTOR signaling PDK PDK1 inhibit Inhibitor kinase-1 PDK-1 PDK1 inhibitor phosphoinositide-dependent MP-7 MP 7 inhibitor